Search Results - nanomedicine

4 Results Sort By:
Nanococktail for combination therapy, compositions, methods, and uses
INV-20007 Background It is difficult to achieve optimal exposure of all agents in combination therapy with drugs that exhibit different properties. Nanoparticle delivery systems are a well-known means to modify the pharmacokinetics and distribution of drugs. Northeastern researchers have demonstrated that through nanoencapsulation, similar pharmacokinetic...
Published: 1/27/2025   |   Updated: 3/21/2024   |   Inventor(s): Srinivas Sridhar, Paige Baldwin, Bijay Singh
Keywords(s): Combination therapy, Drug Delivery, Nanomedicine, Therapeutic, Treatment
Category(s): -Nanotechnology, -Materials
Macrophage-Targeted Multi-Compartmental Delivery Systems
INV-1028 Background Macrophages are important immune cells in the body that regulate different biological processes involved in inflammatory and infectious diseases. Macrophages originate from the mononuclear phagocyte system (MPS) in the bone marrow. The MPS system comprises of monocytes and tissue, it matures into a larger phagocytic cell called...
Published: 1/27/2025   |   Updated: 3/21/2024   |   Inventor(s): Mansoor Amiji, Husain Attarwala, Shardool Jain, Mayur Kalariya
Keywords(s): Biotech, Breast Cancer, Cancer, Chemotherapy, Drug Delivery, Drugs, Health, Medical, Nanomedicine
Category(s): -Biomedical Materials, -Nanomedicine, -Cancer, -Health, Technology Classifications > 1. Life Science > Drug Delivery
Man 1-2 Man-PEGylated Derivative as a Tool for in vitro and in vivo Dendritic Cell Targeting
INV-1151 Background The immune system (IS) has a delicate equilibrium between its cells. The most important cells of the IS are the B lymphocytes (BL), macrophages (MO), and dendritic cells (DC), so-called antigen presenting cells (APC). They are the key-linkers between the innate and the adaptive immunity, which is a crucial factor that will lead...
Published: 1/27/2025   |   Updated: 3/21/2024   |   Inventor(s): Vladimir Torchilin, Tatiana Levchenko, Juan Pappalardo, Stefano Salmaso, Micaela Toniutti
Keywords(s): Cancer, Chemistry, COVID, Drug Delivery, Genome, Health, Healthcare Innovation, Medical, Nanomedicine, Research Tool
Category(s): -Nanomedicine, -Cancer, -Health, Technology Classifications > 1. Life Science > Drug Delivery, Technology Classifications > 1. Life Science > Therapeutics
Nanopreparation for Co-Delivery of Drugs and siRNA
INV-13004 Background Overexpression of p‑glycoprotein (encoded by MDR1 gene) is often associated with multidrug-resistant cancer. This protein leads to drug resistance by the efflux of chemotherapeutic drugs from the cancerous cells. Small interfering RNA (siRNA), also known as post-transcriptional gene silencer, can suppress the expression of specific...
Published: 1/27/2025   |   Updated: 3/21/2024   |   Inventor(s): Vladimir Torchilin, Swati Biswas
Keywords(s): Delivery, Drug Delivery, Healthcare Innovation, Medical, Nanomedicine, Nanotechnology, Pharmaceutical Composition, Therapeutic
Category(s): -Nanotechnology, -Nanomedicine, -Pharmaceutical Composition, -Health, Technology Classifications > 1. Life Science > Drug Delivery, Technology Classifications > 1. Life Science > Therapeutics
Copyright© Northeastern University. All rights reserved. Powered by Inteum.